Celgene: Morgan Stanley Global Healthcare Conference (Celgene) - Sep 19, 2015 - Anticipated data from P1 trial (NCT02367183) for Crohn’s disease in 2017; Anticipated approval for Crohn’s disease in 2019
Anticipated P1 data • Anticipated regulatory • Inflammatory Bowel Disease
|